Literature DB >> 20660165

Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases.

Alexander I Chernyavsky1, Juan Arredondo, Valentin Galitovskiy, Jing Qian, Sergei A Grando.   

Abstract

SLURP-1 (secreted mammalian Ly-6/urokinase plasminogen activator receptor-related protein-1) is a novel auto/paracrine cholinergic peptide that can bind to α(7)-nicotinic acetylcholine receptor (nAChR), a high Ca(2+)-permeable ion channel coupled to regulation of nuclear factor-κB (NF-κB) expression. Elucidation of intracellular signaling events elicited by SLURP-1 is crucial for understanding the molecular mechanism of functioning of this novel hormone-like peptide that alters vital cell functions and can protect from tumorigenic transformation. In this study, we sought to dissect out the role of α(7)-nAChR in mediating the biologic effects of recombinant SLURP-1 on the immortalized line of human oral keratinocytes Het-1A. A multifold upregulation of the NF-κB expression at the mRNA and protein levels by SLURP-1 was only slightly diminished due to elimination of Na(+), whereas in Ca(2+)-free medium the effect of SLURP-1 was inhibited by >50%. Both in the absence of extracellular Ca(2+) and in the presence of Cd(2+) or Zn(2+), the SLURP-1-dependent elevation of NF-κB was almost completely blocked by inhibiting MEK1 activity. Downstream of α(7)-nAChR, the SLURP-1 signaling coupled to upregulation of NF-κB also involved Jak2 as well as Ca(2+)/calmodulin-dependent kinase II (CaMKII) and protein kinase C (PKC), whose inhibition significantly (P < 0.05) reduced the SLURP-1-induced upregulation of NF-κB. The obtained results indicated that activation of α(7)-nAChR by SLURP-1 leads to upregulation of the NF-κB gene expression due to activation of the Raf-1/MEK1/ERK1/2 cascade that proceeds via two complementary signaling pathways. One is mediated by the Ca(2+)-entry dependent CaMKII/PKC activation and another one by Ca(2+)-independent involvement of Jak2. Thus, there exists a previously not appreciated network of noncanonical auto/paracrine ligands of nAChR of the Ly-6 protein family, which merits further investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660165      PMCID: PMC2980298          DOI: 10.1152/ajpcell.00216.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  84 in total

1.  The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Evert Karlsson; Ignaz Wessler; Sergei A Grando
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

2.  Identification of lynx2, a novel member of the ly-6/neurotoxin superfamily, expressed in neuronal subpopulations during mouse development.

Authors:  Eric Dessaud; Danièle Salaün; Odile Gayet; Marie Chabbert; Odile deLapeyrière
Journal:  Mol Cell Neurosci       Date:  2005-10-19       Impact factor: 4.314

Review 3.  Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance.

Authors:  Sergei A Grando; Mark R Pittelkow; Karin U Schallreuter
Journal:  J Invest Dermatol       Date:  2006-09       Impact factor: 8.551

4.  Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice.

Authors:  Paul P Lau; Lan Li; Aksam J Merched; Alan L Zhang; Kerry W S Ko; Lawrence Chan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-27       Impact factor: 8.311

5.  Long term environmental tobacco smoke activates nuclear transcription factor-kappa B, activator protein-1, and stress responsive kinases in mouse brain.

Authors:  Sunil K Manna; Thirumalai Rangasamy; Kimberly Wise; Shubhashish Sarkar; Shishir Shishodia; Shyam Biswal; Govindarajan T Ramesh
Journal:  Biochem Pharmacol       Date:  2006-03-29       Impact factor: 5.858

6.  SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium.

Authors:  Juan Arredondo; Alexander I Chernyavsky; David L Jolkovsky; Robert J Webber; Sergei A Grando
Journal:  J Cell Physiol       Date:  2006-07       Impact factor: 6.384

7.  Nicotine induces tissue factor expression in cultured endothelial and smooth muscle cells.

Authors:  P Cirillo; S DE Rosa; M Pacileo; A Gargiulo; A Leonardi; V Angri; S Formisano; M Chiariello
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

8.  Biological effects of SLURP-1 on human keratinocytes.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Robert J Webber; Sergei A Grando
Journal:  J Invest Dermatol       Date:  2005-12       Impact factor: 8.551

9.  Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  Cancer Biol Ther       Date:  2006-05-13       Impact factor: 4.742

Review 10.  Cholinergic control of epidermal cohesion.

Authors:  Sergei A Grando
Journal:  Exp Dermatol       Date:  2006-04       Impact factor: 3.960

View more
  28 in total

1.  Novel cholinergic peptides SLURP-1 and -2 regulate epithelialization of cutaneous and oral wounds.

Authors:  Alexander I Chernyavsky; Mina Kalantari-Dehaghi; Courtney Phillips; Steve Marchenko; Sergei A Grando
Journal:  Wound Repair Regen       Date:  2011-12-13       Impact factor: 3.617

2.  Nicotinic receptor signaling in nonexcitable epithelial cells: paradigm shifting from ion current to kinase cascade. Focus on "Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases".

Authors:  Andrzej Slominski
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-25       Impact factor: 4.249

3.  CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS.

Authors:  Xitong Dang; Brian P Eliceiri; Andrew Baird; Todd W Costantini
Journal:  FASEB J       Date:  2015-02-13       Impact factor: 5.191

4.  Mechanisms for nicotine in the development and progression of gastrointestinal cancers.

Authors:  Kendal Jensen; Syeda Afroze; Md Kamruzzaman Munshi; Micheleine Guerrier; Shannon S Glaser
Journal:  Transl Gastrointest Cancer       Date:  2012-04

5.  Burn Injury Alters Epidermal Cholinergic Mediators and Increases HMGB1 and Caspase 3 in Autologous Donor Skin and Burn Margin.

Authors:  Casey J Holmes; Jennifer K Plichta; Richard L Gamelli; Katherine A Radek
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

6.  A Human-Specific α7-Nicotinic Acetylcholine Receptor Gene in Human Leukocytes: Identification, Regulation and the Consequences of CHRFAM7A Expression.

Authors:  Todd W Costantini; Xitong Dang; Maryana V Yurchyshyna; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  Mol Med       Date:  2015-04-03       Impact factor: 6.354

7.  Human secreted proteins SLURP-1 and SLURP-2 control the growth of epithelial cancer cells via interactions with nicotinic acetylcholine receptors.

Authors:  E N Lyukmanova; M L Bychkov; G V Sharonov; A V Efremenko; M A Shulepko; D S Kulbatskii; Z O Shenkarev; A V Feofanov; D A Dolgikh; M P Kirpichnikov
Journal:  Br J Pharmacol       Date:  2018-04-24       Impact factor: 8.739

Review 8.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

Review 9.  Why do we study animal toxins?

Authors:  Yun Zhang
Journal:  Dongwuxue Yanjiu       Date:  2015-07-18

10.  SLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator.

Authors:  Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-28       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.